Aurinia Reports Second Quarter Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 4c
August 9, 2018 4:42 PM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.19), $0.04 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
... More